India Cancer Surgery Site’s Post

Colon Cancer is a severe condition that requires the Best Treatment. It typically affects older adults, but early Colon Cancer detection can save lives. Dharan Cancer Specialty Centre is here to help you combat Colon Cancer using the latest cutting-edge technology. We employ state-of-the-art diagnostic techniques, such as advanced imaging and genetic testing, to identify any potential risks or signs of Colon Cancer. By combining innovative technologies and extensive research, we strive to provide top-notch care for our patients. Our highly experienced Oncologists are committed to providing the best quality care and offer a spectrum of treatments, including Chemotherapy, Radiation, Immunotherapy, Targeted therapy, and Surgical procedures. Take control of your health and schedule a consultation with our specialists at Dharan Cancer Specialty Centre. Together, let's beat Colon Cancer and reclaim your health! #treatmentforcoloncancer #rectumcancer #colorectalcancer #earlyscreening #coloncancer #cancertreatment #cancerpatients #cancercare #cancercentre #ComprehensiveCancerCare #colorectalcancerawareness #bowelcancer #ColorectalCancerScreening #coloncancer #chemotherapy #TargetedTherapy #RadiationTherapy #immunotherapy For Further Query #Call: +91 - 99439 39990 #Visit: https://lnkd.in/gY4mhra

Some cancers roar; NET Cancer whispers. This November 10, on World NET Cancer Day, let’s bring awareness to a disease that hides in plain sight. •Signs: NET Cancer often hides behind common symptoms like fatigue, flushing, stomach pain, and unexplained weight changes — symptoms that can easily be overlooked or misattributed. •Diagnosis: Detecting NETs requires specialized testing, including advanced imaging (such as CT or MRI scans), hormone marker analysis through blood and urine tests, and sometimes a biopsy to confirm the diagnosis. •Treatment: Options for treating NET Cancer include targeted therapies, surgery to remove tumors, and peptide receptor radionuclide therapy (PRRT), a form of molecular therapy designed specifically for NETs. Help us break through the silence, spot NET Cancer early, and give patients the fighting chance they deserve. Know the signs, demand answers, and save a life today! #WorldNETCancerDay #SpotNETCancerEarly #NeuroendocrineTumors #NETAwareness #FightNETCancer #SaveLives #KnowTheSigns #DiagnosisMatters #EarlyDetection #CancerAwareness

🚨 Colorectal Cancer Screening Saves Lives🚨 HCD International is committed to keeping health plan members informed about colorectal cancer screenings. Regular screenings can help detect cancer early when it’s most treatable. Here’s a quick overview of the four main types of screenings and their recommended frequency: 🧡Stool Sample Test (FIT) –Tests for blood in stools include yearly Guaiac-based Fecal Occult Blood Test (gFOBT) and Fecal Immunochemical Test (FIT)-DNA tests every 3 years. 🧡Flexible Sigmoidoscopy – Doctors perform a Flexible Sigmoidoscopy every 5 or 10 years, alongside a yearly FIT test, to check for polyps or cancer in the lower rectum using a thin, flexible tube. 🧡Colonoscopy – Screening is recommended every 10 years for those at average risk for colon cancer. A long, flexible lighted tube checks for polyps or cancer in the rectum and colon, allowing for the removal of most polyps and cancer. 🧡CT Colonography –In 5 years, virtual colonoscopy using X-rays and computers will provide doctors with images of the entire colon for analysis. 🔗 For more information on HEDIS Gap Closures support, contact us at info@hcdi.com. #ColonCancer #Colorectalcancer #CancerAwareness #ColonocancerAwareness #ColorectalCancerScreenings #HCDI #HCDinternational #unitedstates #Maryland #WashingtonDC #HealthPlans #Healthoutcomes #Healthequity #CancerPrevention #HEDIS #HEDISGapClosures

According to the 𝘚𝘪𝘯𝘨𝘢𝘱𝘰𝘳𝘦 𝘊𝘢𝘯𝘤𝘦𝘳 𝘙𝘦𝘨𝘪𝘴𝘵𝘳𝘺 𝘈𝘯𝘯𝘶𝘢𝘭 𝘙𝘦𝘱𝘰𝘳𝘵 2021, uterine and ovarian cancer rates have risen significantly since 1968, with ovarian cancer cases increasing from 5.9 to 12 per 100,000 population. With ovarian cancer rates on the rise in Singapore, the need for early and accurate differentiation between benign and malignant ovarian cysts is more critical than ever. Early detection is essential, as both cancers are more treatable in their initial stages. Solutions like 𝗢𝘃𝗮𝗖𝗶𝘀®—𝗮𝗻 𝗶𝗻𝘁𝗿𝗮-𝗼𝗽𝗲𝗿𝗮𝘁𝗶𝘃𝗲, 𝗽𝗼𝗶𝗻𝘁-𝗼𝗳-𝗰𝗮𝗿𝗲 𝗱𝗲𝘃𝗶𝗰𝗲 𝘁𝗵𝗮𝘁 𝗱𝗶𝘀𝘁𝗶𝗻𝗴𝘂𝗶𝘀𝗵𝗲𝘀 𝗯𝗲𝗻𝗶𝗴𝗻 𝗳𝗿𝗼𝗺 𝗺𝗮𝗹𝗶𝗴𝗻𝗮𝗻𝘁 𝗼𝘃𝗮𝗿𝗶𝗮𝗻 𝗰𝘆𝘀𝘁𝘀 𝘄𝗶𝘁𝗵𝗶𝗻 𝗷𝘂𝘀𝘁 𝟭𝟱 𝗺𝗶𝗻𝘂𝘁𝗲𝘀—provide surgeons with real-time insights, supporting timely, informed decisions and ultimately enhancing patient outcomes. Connect with us at INEX Innovate to learn more about 𝗢𝘃𝗮𝗖𝗶𝘀® now. #INEX #Innovate #INEXInnovate #iGene #iGeneLaboratory #HealthcareInnovation #MedicalDevices #HealthcareTechnology #BioTechnology #FutureofHealthcare #WomenHealth #WomanHealth #Ovacis #OvarianCancer #Ovarian #Cancer #GynaecologicalCancer #CancerDetection #EarlyDetection #Diagnostics #Singapore

November is Pancreatic Cancer Awareness Month—a time to shed light on one of the most challenging cancers to diagnose and treat. Often called the “silent killer,” pancreatic cancer rarely presents symptoms in its early stages, making timely diagnosis an uphill battle. By the time it manifests noticeable signs, the disease is often advanced, leaving patients and their families with limited options. Despite these challenges, advancements in medical technology and treatment strategies have brought hope. From early detection tools like liquid biopsies to cutting-edge treatments such as targeted therapy, immunotherapy, and minimally invasive surgical techniques, science is making strides to improve outcomes and extend lives. As healthcare professionals and advocates, we must continue to raise awareness about pancreatic cancer, encourage regular health check-ups, and advocate for more research funding.. Let’s work towards early detection and better care for those affected. #PancreaticCancerAwarenessMonth #EarlyDetection #CancerCare #HealthcareInnovation Narayana Health Naveen Sharma Dharamshila Narayana Superspeciality Hospital

As we close out the year, I'm taking a moment to celebrate one of the many research breakthroughs in the fight against prostate cancer—made possible through continued investment in cancer research. Prostate cancer remains a formidable challenge in the USA, accounting for ~1/3 of all new cancer diagnoses in men, and placing significant burden on patients, families, and healthcare systems. While screening and early detection are key to reducing mortality, concerns about over-treatment of men with elevated PSA levels have been a longstanding challenge. Enter the role of MRI. A game changer! As exemplified in Hamm et al., MRI can safely differentiate between men with high PSA levels who need a biopsy and those who can be monitored through active surveillance. This advancement enables us to: -Reduce unnecessary biopsies and minimize their associated risks. -Detect clinically significant cancers earlier and with greater accuracy. -Alleviate patient anxiety through a less invasive and more precise approach to assessment. This is more than a technological improvement—it’s a step forward in precision medicine that has the potential to transform prostate cancer care. As we look ahead to 2025 and beyond, it’s essential to support the widespread adoption of evidence-based practices like these. The stakes are high, but with continued innovation and collaboration, we can shift the trajectory of prostate cancer and save lives. Here’s to more wins in the fight against cancer in the year ahead! https://lnkd.in/eaH5Y6ET #ProstateCancer #CancerResearch #PrecisionMedicine #MensHealth #MRI #ProstateHealth #EarlyDetection #CancerCare #InnovationInHealthcare #HealthcareAdvances #HealthEquity

#AI for skin cancer can #impact #behaviour #change Cancer is on the rise among younger people. According to a study published in BMJ Oncology, the number of under-50s worldwide being diagnosed with cancer has risen by nearly 80% in three decades. And, over the last decade #melanoma skin cancer incidence rates have increased by almost two-fifths (38%) with #Spain seeing a steady incidence increase of 2.4% during this time. If detected early enough, skin cancer is easily treated and #prognosis is very good. But busy lives and competing concerns mean fewer people are getting checked out, resulting in delays to #diagnosis and treatment, which is dramatically changing the survival rates. Those who do, often wait to speak to a doctor. In fact, new research from #Bupa, Attitudes Towards Digital Healthcare, indicates only 9% of people would immediately go to get a mole they were concerned about examined by a #professional. However, the same research found that if people were able to have a mole assessed by an #AI-powered phone app at the time of their choosing, that percentage increases more than threefold (33%). This signifies #emerging technology can have a significant impact on positive behaviour change in healthcare and improve clinical outcome of a potentially severe disease.

Targeted low-dose computed tomography (LDCT) screening for lung cancer is widely considered the gold standard for detecting the disease early. To demonstrate the value of screening as a cost-effective way to improve outcomes, we developed five factsheets with policymakers in mind. They provide a summary of key evidence needed to help governments commit to the implementation of lung cancer screening. While there’s plenty of evidence for action, some policymakers are still not fully aware of the burden lung cancer places on people, or its implications for health systems and economies. #DetectEarlySaveLives #LungCancerAwarenessMonth Find out more and share them today: https://lnkd.in/e9a4U9QH

#Radiation #Therapy for #Cancer #Treatment A #review article presented by ✍ M Waheed Roomi #Introduction The world wide incidence of #cancer is a major public health concern and it is a global threat. Cancer is the second leading cause of #death in the #WesternWorld and the leading cause of death, globally.... #Apoptosis Apoptosis is often induced after #radiation. The initiation of apoptosis is mainly activated by two different pathways - #intrinsic and #extrinsic.... #Autophagy It is known that RT is one of the stressors that induce autophagy in both normal and cancer cells. Autophagy has been shown to play a dual role with evidence for both #cytoprotective and/or #cytotoxic effects.... #Conclusions The goals of RT can vary depending on factors such as the type of cancer, stage of disease, and overall treatment plan. However, the primary objectives of radiation therapy in cancer treatment include.... To get full-length article click here https://lnkd.in/g99F6Dgv We do accept #PPTs and #Video Articles to be publish within our Journal. You can send us your article to given email #Email: onlinescientificresearch@gmail.com

New liquid biopsy, couples with AI-driven algorithm to detect ovarian cancer. DELFI Diagnostics results of research at the American Association for Cancer Research Annual Meeting on 10 April. This retrospective study examined blood samples from 600 women, for cell-free DNA fragments and traditional markers CA125 and HE4 Cell-free DNA fragments are released into the blood stream by rapidly-growing cancer cells, which don’t have the usual well-ordered pattern of DNA that non-cancerous cells have. This technology is gathering pace, with liquid biopsies being researched for all sorts of cancer from lung to breast. With a specificity of 99% and sensitivity ranging from 69% (stage I), 76% (stage II), 85% (stage III) and 100% (stage IV) for ovarian cancer, this compares favourably with the CA125 test (sensitivities of 40%, 66%, 62%, and 100%). #Ovariancancer has poor survival rates due to its ability to progress without symptoms, so #screening tests with low false positive rates (almost zero in this study) can be incredibly powerful tools to address morbidity and mortality. More research is needed, but it's great to see non-invasive technologies such as #liquidbiopsies empowering patients to gain insights into their health, in order to stay healthy. #democratisinghealthcare #biomarkers